20608 ⎘
Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
ADHESION MOLECULE INHIBITION FOR STEM CELL THERAPIES
#2CD127 EXPRESSION INVERSELY CORRELATES WITH FOXP3 AND SUPPRESSIVE FUNCTION OF CD4+ TREGS
#3ENHANCED MSC PREPARATIONS
#4NON-GENOTOXIC CONDITIONING REGIMEN FOR STEM CELL TRANSPLANTATION
#5METHODS FOR EXPANDING AND ACTIVATING yo T CELLS FOR THE TREATMENT OF CANCER AND RELATED MALIGNANCIES
#6COMPOSITIONS AND METHODS FOR ANTIGEN-SPECIFIC TOLERANCE
#7INDUCIBLE REGULATORY T-CELL GENERATION FOR HEMATOPOIETIC TRANSPLANTS
#8MESENCHYMAL STEM CELLS FOR ORAL INFLAMMATION TREATMENT
#9METHOD AND COMPOSITION FOR INDUCING TOLERANCE
#10LYMPH NODE AS A SITE FOR TRANSPLANTATION, ORGANOGENESIS AND FUNCTION FOR MULTIPLE TISSUES AND ORGANS
#11THERAPIES WITH LANTHIONINE C-LIKE PROTEIN 2 LIGANDS AND CELLS PREPARED THEREWITH
#12ENGINEERED REGULATORY T CELL
#13LYMPH NODE AS A SITE FOR TRANSPLANTATION, ORGANOGENESIS AND FUNCTION FOR MULTIPLE TISSUES AND ORGANS
#14Cultured Thymus Tissue Transplantation Promotes Donor-Specific Tolerance to Allogeneic Solid Organ Transplants
#15ISOLATION OF STABLE REGULATORY T CELLS AND USES THEREOF
#16Bone Marrow Harvesting and Storage
#17Methods and Compositions for Xenotransplantation
#18PRIMED UTERINE-DERIVED REGENERATIVE CELL COMPOSITIONS AND USES THEREOF
#19PRECURSORY REGULATORY CYTOTROPHOBLAST CELLS AND USES THEREOF
#20METHOD FOR PRODUCING AN ANTI-LAG-3 ANTIBODY
#21METHOD FOR ENHANCING THE SUPPRESSIVE PROPERTIES OF TREG CELLS
#22METHODS FOR ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
#23METHODS OF INDUCING ORGAN TRANSPLANTATION IMMUNE TOLERANCE AND ASSOCIATED COMPOSITIONS AND METHODS
#24REGULATORY T CELL EPITOPES
#25MESENCHYMAL STEM CELLS EXPRESSING TNF-ALPHA RECEPTORS
#26NOVEL COMBINATIONS FOR ANTIGEN BASED THERAPY
#27METHOD AND COMPOSITION FOR INDUCING TOLERANCE
#28METHODS OF TREATING AUTOIMMUNE DISEASE
#29METHODS FOR INDUCING AN IMMUNE RESPONSE BY ADMINISTERING ACTIVATED MESENCHYMAL STEM CELLS
#30ISOLATION AND USE OF HUMAN LYMPHOID ORGAN-DERIVED SUPPRESSIVE STROMAL CELLS
#31USE OF CART19 TO DEPLETE NORMAL B CELLS TO INDUCE TOLERANCE
#32ADIPOSE COMPOSITIONS AND METHODS OF USE THEREOF
#33STRATEGIES TO PREVENT AND/OR TREAT IMMUNE RESPONSES TO SOLUBLE ALLOFACTORS
#34METHOD FOR EX-VIVO EXPANSION OF REGULATORY T CELLS WITH ENHANCED SUPPRESSIVE FUNCTION FOR CLINICAL APPLICATION IN IMMUNE MEDIATED DISEASES
#35T CELL REGULATION
#36GENETICALLY MODIFIED ANTI-THIRD PARTY CENTRAL MEMORY T CELLS AND USE OF SAME IN IMMUNOTHERAPY
#37ENHANCED MSC PREPARATIONS
#38CELLULAR COMPOSITIONS DERIVED FROM DECEASED DONORS TO PROMOTE GRAFT TOLERANCE AND MANUFACTURE AND USES THEREOF
#39CELLULAR COMPOSITIONS DERIVED FROM PRIOR ORGAN DONORS AND METHODS OF MANUFACTURE AND USE THEREOF
#40METHODS FOR EXPANDING AND ACTIVATING yo T CELLS FOR THE TREATMENT OF CANCER AND RELATED MALIGNANCIES
#41ANTI-HLA-A2 ANTIBODIES AND USES THEREOF
#42Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy
#43VETO CELLS GENERATED FROM MEMORY T CELLS
#44COMPOSITIONS AND METHODS FOR INHIBITING THE EXPRESSION OF MULTIPLE GENES
#45T CELL RECEPTOR-DEFICIENT CHIMERIC ANTIGEN RECEPTOR T-CELLS AND METHODS OF USE THEREOF
#46METHOD OF TREATING GRAFT VERSUS HOT DISEASE
#47METHODS FOR TREATING CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
#48Suppression of Microglial Activation with Innate Lymphoid Cells
#49CD127 EXPRESSION INVERSELY CORRELATES WITH FOXP3 AND SUPPRESSIVE FUNCTION OF CD4+ TREGS
#50REGULATORY T CELLS GENETICALLY MODIFIED FOR THE LYMPHOTOXIN ALPHA GENE AND USES THEREOF
#51MYELOMA-SPECIFIC IMMUNITY REQUIRES THE DIFFERENTIATION OF STEM-LIKE MEMORY T CELLS IN THE BONE MARROW
#52NF-B signaling pathway-manipulated dendritic cells
#53Cell
#54Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment
#55COMPOSITIONS AND METHODS FOR TREATMENT OF LIQUID CANCERS
#56TREATMENT OF PARKINSON'S DISEASE BY IMMUNE MODULATION AND REGENERATIVE MEANS
#57METHODS FOR ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
#58COMPOSITIONS AND METHODS FOR IN VITRO CULTIVATION AND/OR EXPANSION OF REGULATORY T CELLS
#59Combined organ and hematopoietic cells for transplantation tolerance of grafts
#60Probiotic immunomodulatory compositions
#61Cell populations having immunoregulatory activity, method for isolation and uses
#62METHOD FOR OBTAINING REGULATORY T CELLS DERIVED FROM THYMIC TISSUE AND USE OF SAID CELLS AS CELL IMMUNOTHERAPY IN IMMUNE SYSTEM DISORDERS
#63Method for preparing immune-tolerized extracellular vesicle containing lactate dehydrogenase band peroxisome proliferator-activated receptor gamma coactivator 1-alpha, and composition comprising the extracellular vesicle
#64TREATMENT OF AUTISM SPECTRUM DISORDER AND ASSOCIATED NEUROINFLAMMATION USING FIBROBLASTS AND DERIVATIVES THEREOF
#65LYMPH NODE AS A SITE FOR TRANSPLANTATION, ORGANOGENESIS AND FUNCTION FOR MULTIPLE TISSUES AND ORGANS
#66METHOD OF INDUCING ANTIGEN-SPECIFIC TOLERANCE IN A SUBJECT BY ADMINISTERING A COMPOSITION COMPRISING AN APOPTOTIC BODY SURROGATE AND COUPLED IMMUNODOMINANT ANTIGENIC EPITOPES ASSOCIATED WITH AUTOIMMUNE DISEASE
#67METHOD FOR OBTAINING IMMUNO-SUPPRESSIVE DENDRITIC CELLS
#68IN VIVO TARGETING OF CELLS WITH LIGAND-CONJUGATED PARTICLES
#69MESENCHYMAL STEM CELLS FOR ORAL INFLAMMATION TREATMENT
#70METHODS FOR PRODUCING REGULATORY B CELLS AND USES THEREOF
#71PLACENTA DERIVED ADHERENT CELLS FOR IMPROVED XENOPLANTATION
#72Compositions Comprising Apoptotic Signaling and Methods for Induction of Antigen-Specific Tolerance
#73TUNABLE ENDOGENOUS PROTEIN DEGRADATION
#74CELLS EXPRESSING PARATHYROID HORMONE 1 RECEPTOR AND USES THEREOF
#75CONDITIONING AGENTS FOR USE IN ALLOGENEIC HEMATOPOETIC STEM CELL TRANSPLANTATION
#76Genetically modified anti-third party central memory T cells and use of same in immunotherapy
#77Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants
#78Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith
#79METHOD FOR EX-VIVO EXPANSION OF REGULATORY T CELLS WITH ENHANCED SUPPRESSIVE FUNCTION FOR CLINICAL APPLICATION IN IMMUNE MEDIATED DISEASES
#80CONSTITUTIVE EXPRESSION OF COSTIMULATORY LIGANDS ON ADOPTIVELY TRANSFERRED T LYMPHOCYTES
#81CEACAM1 MEDIATED PROTECTIVE IMMUNITY
#82CEACAM1 BASED CANCER THERAPY AND DIAGNOSIS
#83CD4 T cells provide antibody access to immunoprivileged tissue
#84Precursory regulatory cytotrophoblast cells and uses thereof
#85IMMUNOMODULATORY PROPERTIES OF MULTIPOTENT ADULT PROGENITOR CELLS AND USES THEREOF
#86Regulatory T cell epitopes
#87TARGETED PROTEIN DEGRADATION TO ATTENUATE ADOPTIVE T-CELL THERAPY ASSOCIATED ADVERSE INFLAMMATORY RESPONSES
#88VIRUS-LIKE PARTICLES WHICH CAN BE USED IN THE TREATMENT OF ALLERGIES
#89PSAMMAPLIN A FOR MODULATING IDO EXPRESSION
#90INDUCIBLE REGULATORY T-CELL GENERATION FOR HEMATOPOIETIC TRANSPLANTS
#91Methods for inducing an immune response by administering activated mesenchymal stem cells
#92T CELL REGULATION
#93IMMUNOMODULATORY PROPERTIES OF MULTIPOTENT ADULT PROGENITOR CELLS AND USES THEREOF
#94Veto cells generated from memory T cells
#95Methods of administering mesenchymal stem cells activated by cytokines for enhancing immunosuppression
#96IMMUNOMODULATORY PROPERTIES OF MULTIPOTENT ADULT PROGENITOR CELLS AND USES THEREOF
#97Combined organ and hematopoietic cells for transplantation tolerance of grafts
#98NON-GENOTOXIC CONDITIONING REGIMEN FOR STEM CELL TRANSPLANTATION
#99Mesenchymal stem cells expressing TNF-α receptors
#100METHODS OF TREATING OR PREVENTING NEUROLOGICAL DISEASES
#101Engineered regulatory T cell
#102Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells
#103Methods and Materials for the Generation of Regulatory T Cells
#104METHOD OF TREATING GRAFT VERSUS HOST DISEASE
#105Method for enhancing the suppressive properties of Treg cells
#106FLT3L-FC fusion proteins
#107METHOD FOR OBTAINING REGULATORY T CELLS DERIVED FROM THYMIC TISSUE AND USE OF SAID CELLS AS CELL IMMUNOTHERAPY IN IMMUNE SYSTEM DISORDERS
#108Therapeutic pooled blood apoptotic cell preparations and uses thereof
#109Cellular compositions derived from prior organ donors and methods of manufacture and use thereof
#110Methods for allogenic hematopoietic stem cell transplantation
#111Methods for allogenic hematopoietic stem cell transplantation
#112FLT3L-Fc FUSION PROTEINS AND METHODS OF USE
#113METHODS FOR ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
#114Treatment of inflammatory diseases using placental stem cells
#115Regulatory T cells genetically modified for the lymphotoxin alpha gene and uses thereof
#116METHODS OF TREATING AUTOIMMUNE DISEASE
#117Method of treating psoriatic arthritis with increased interval dosing of anti-IL12/23 antibody
#118COMPOSITION FOR ENDOGENOUS PRODUCTION OF CHECKPOINT PROTEIN PRECURSORS
#119Method for treating skin diseases using a humanized antibody that binds to vimentin
#120Precursory regulatory cytotrophoblast cells and uses thereof
#121Regulatory T cell expressing a chimeric antigen receptor
#122Virus-like particles which can be used in the treatment of autoimmune diseases
#123ADHERENT CELLS FROM PLACENTA AND USE OF SAME IN DISEASE TREATMENT
#124PROTECTION OF THE VASCULAR ENDOTHELIUM FROM IMMUNOLOGICALLY MEDIATED CYTOTOXIC REACTIONS WITH HUMAN CD34-NEGATIVE PROGENITOR CELLS
#125Early apoptotic cells for use in treating sepsis
#126Anti-HLA-A2 antibodies, related chimeric antigen receptors, and uses thereof
#127Citrullinated peptides that bind to types of MHC class II and their use on diagnosis and treatment
#128Multi-Chimeric Cell and Therapy for Transplantation and Treatment of Immune Deficiencies and Genetic Disorders
#129Combined organ and hematopoietic cells for transplantation tolerance of HLA mismatched grafts
#130ANTI-TLR4 ANTIBODIES AND USES THEREOF
#131T cell compositions with improved phenotypic properties
#132STRATEGIES TO PREVENT AND/OR TREAT IMMUNE RESPONSES TO SOLUBLE ALLOFACTORS
#133COMPOSITIONS AND METHODS FOR IMMUNE TOLERANCE
#134Compositions and methods for preventing and treating graft versus host disease
#135Novel Combinations for Antigen Based Therapy
#136METHOD FOR DETERMINING THE RISK TO DEVELOP TYPE 1 DIABETES
#137Indole regulation of antigen presenting cells
#138Combination immune therapy and cytokine control therapy for cancer treatment
#139Method for detecting CD4+CD25+glycoprotein A33(GPA33)high and/or CD4+CD127-GPA33high T cells
#140Cellular compositions derived from deceased donors to promote graft tolerance and manufacture and uses thereof
#141ISOLATION AND USE OF HUMAN LYMPHOID ORGAN-DERIVED SUPPRESSIVE STROMAL CELLS
#142Compositions and Methods for Antigen-Specific Tolerance
#143Human Bone-Forming Cells in the Treatment of Inflammatory Rheumatic Diseases
#144Suppression of Microglial Activation with Innate Lymphoid Cells
#145METHODS AND COMPOSITIONS FOR IMMUNOMODULATION
#146Compositions and methods for in vitro cultivation and/or expansion of regulatory T cells
#147Modulation of immunity and CEACAM1 activity
#148Syndecan-2 compositions and methods of use
#149Combined organ and hematopoietic cells for transplantation tolerance of grafts
#150Probiotic immunomodulatory compositions
#151Methods for treating chronic lymphocytic leukemia (CLL)
#152Combined organ and hematopoietic cells for transplantation tolerance of grafts
#153Veto cells generated from memory T cells
#154Cellular compositions derived from prior organ donors and methods of manufacture and use thereof
#155Combined organ and hematopoietic cells for transplantation tolerance of grafts
#156COMPOSITIONS AND METHODS OF TREATING CANCER
#157Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants
#158PREVENTION OF GRAFT REJECTION BY PRIOR USE OF MODIFIED GRAFTS
#159Membrane for immunoisolation, chamber for transplantation, and device for transplantation
#160USE OF MESENCHYMAL STEM CELLS AND PARTS THEREOF
#161Methods and compositions for immunomodulation
#162Induced dendritic cells and uses thereof
#163Methods for treating autoimmune diseases incorporating an anti-LAG3 antibody
#164METHODS OF TREATING OR PREVENTING NEUROLOGICAL DISEASES
#165Combined organ and hematopoietic cells for transplantation tolerance of grafts
#166Combined organ and hematopoietic cells for transplantation tolerance of grafts
#167Methods for expanding and activating γδ T cells for the treatment of cancer and related malignancies
#168Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith
#169CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE THEREOF
#170Combined organ and hematopoietic cells for transplantation tolerance of grafts
#171Bone marrow harvesting and storage
#172Combined organ and hematopoietic cells for transplantation tolerance of grafts
#173METHODS AND MATERIALS FOR THE GENERATION OF REGULATORY T CELLS
#174Methods of producing activated mesenchymal stem cells
#175T cell receptor-deficient chimeric antigen receptor T-cells and methods of use thereof
#176Method of treating graft versus host disease
#177Cell derived extracellular vesicles for the treatment of diseases
#178Inducible regulatory t-cell generation for hematopoietic transplants
#179METHODS AND REAGENTS TO TREAT AUTOIMMUNE DISEASES AND ALLERGY
#180Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
#181Combined organ and hematopoietic cells for transplantation tolerance of HLA mismatched grafts
#182TOLEROGENIC DENDRITIC CELLS, METHODS OF PRODUCING THE SAME, AND USES THEREOF
#183Uses of expanded populations of hematopoietic stem/progenitor cells
#184Combined organ and hematopoietic cells for transplantation tolerance of grafts
#185HUCBC TREATMENT OF AMYLOID-ASSOCIATED DISEASE
#186Stem cell with suppressed SOCS and improved immunosuppressive ability and use thereof
#187EXPANSION OF RENEWABLE STEM CELL POPULATIONS
#188Mesenchymal stem cell-derived exosomes and their uses
#189Immunomodulatory properties of MAPCs and uses thereof
#190Human skin equivalents expressing exogenous polypeptides
#191Method and compositions for cellular immunotherapy
#192Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity
#193Methods and compositions for immunomodulation
#194USE OF CART19 TO DEPLETE NORMAL B CELLS TO INDUCE TOLERANCE
#195Method for ex-vivo expansion of regulatory T cells with enhanced suppressive function for clinical application in immune mediated diseases
#196Methods and compounds for eliminating immune responses to therapeutic agents
#197COMPOSITIONS AND METHODS FOR MODULATING TOLL LIKE RECEPTOR SIGNAL
#198Methods of increasing T cell immune response in the treatment of cancer
#199COMPOSITIONS FOR TREATING AN ARTHRITIC CONDITION
#200Combined organ and hematopoietic cells for transplantation tolerance of grafts
#201CD127 expression inversely correlates with FoxP3 and suppressive function of CD4 Tregs
#202NF-KB signaling pathway-manipulated dendritic cells
#203Compositions and methods of treating a T cell mediated disorder
#204Combined organ and hematopoietic cells for transplantation tolerance of grafts
#205Combined organ and hematopoietic cells for transplantation tolerance of grafts
#206NON-GENOTOXIC CONDITIONING REGIMEN FOR STEM CELL TRANSPLANTATION
#207Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells
#208Genetically modified anti-third party central memory T cells and use of same in immunotherapy
#209Methods of transplantation and disease treatment
#210Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment
#211Combined organ and hematopoietic cells for transplantation tolerance of grafts
#212Combined organ and hematopoietic cells for transplantation tolerance of grafts
#213CEACAM1 BASED CANCER THERAPY AND DIAGNOSIS
#214Tunable endogenous protein degradation
#215CEACAM1 MEDIATED PROTECTIVE IMMUNITY
#216Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responses
#217Treatment of graft versus host disease in transplant patients
#218MICROVESICLES ISOLATED FROM MESENCHYMAL STEM CELLS FOR USE AS IMMUNOSUPPRESSIVE AGENTS
#219Modulation of the immune response
#220Methods and kits for labeling, detection and isolation of Foxp3 regulatory T cells, isolated population of Foxp3 regulatory T cells thus obtained and uses thereof
#221METHODS OF TREATING ANTIBODY-MEDIATED REJECTION IN ORGAN TRANSPLANT PATIENTS WITH C1-ESTERASE INHIBITOR
#222High telomerase activity bone marrow mesenchymal stem cells, methods of producing the same and pharmaceuticals and treatment methods based thereon
#223Therapeutic pooled blood apoptotic cell preparations and uses thereof
#224Combination immune therapy and cytokine control therapy for cancer treatment
#225MESENCHYMAL STEM CELLS EXPRESSING TNF-ALPHA RECEPTORS
#226HUMAN STEM CELL-DERIVED NEURAL PRECURSORS FOR TREATMENT OF AUTOIMMUNE DISEASES OF THE CENTRAL NERVOUS SYSTEM
#227Myxoma-treated graft material for cancer treatment
#228METHODS FOR TREATING AN IMMUNE DISORDER-RELATED DISEASE BY REDUCING AUTOREACTIVITY IN A T CELL COMPARTMENT
#229Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
#230Method of treating psoriasis with increased interval dosing of anti-IL12/23 antibody
#231Cells expressing parathyroid hormone 1 receptor and uses thereof
#232INDUCTION OF TOLERANCE IN LUNG ALLOGRAFT TRANSPLANTATION
#233METHOD FOR THE IDENTIFICATION OF TRANSIENTLY FOXP3 NEGATIVE REGULATORY T-CELLS FROM HUMAN PERIPHERAL BLOOD
#234COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING GRAFT VERSUS HOST DISEASE
#235Method for inducing cell reprogramming, and method for producing pluripotent cells
#236CD4 T cells provide antibody access to immunoprivileged tissue
#237Immunosuppressive blood cells and methods of producing the same
#238METHOD FOR EX-VIVO EXPANSION OF REGULATORY T CELLS WITH ENHANCED SUPPRESSIVE FUNCTION FOR CLINICAL APPLICATION IN IMMUNE MEDIATED DISEASES
#239CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHOD FOR ISOLATION AND USES
#240CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHOD FOR ISOLATION AND USES
#241Anti-TLR4 antibodies and uses thereof
#242TREATMENT OF T-CELL MEDIATED IMMUNE DISORDERS
#243Discovery of regulatory T cells programmed to suppress an immune response
#244Compositions and methods for cancer immunotherapy
#245METHODS AND COMPOSITIONS FOR IMPROVING HOMING OF CELLS INCLUDING MESENCHYMAL STEM CELLS
#246Methods and Compositions for Enhancing T Cell Function and Survival
#247Isolated donor MHC-derived peptide and uses thereof
#248Combined organ and hematopoietic cells for transplantation tolerance of grafts
#249Combined organ and hematopoietic cells for transplantation tolerance of HLA mismatched grafts
#250STRATEGIES TO PREVENT AND/OR TREAT IMMUNE RESPONSES TO SOLUBLE ALLOFACTORS
#251Lineage differentiation of encapsulated embryonic stem cells
#252Methods and compositions for immunomodulation
#253Compositions and methods of treating T cell mediated disorder
#254TREATMENT OF INFLAMMATORY DISEASES USING PLACENTAL STEM CELLS
#255ENHANCEMENT OF PLACENTAL STEM CELL POTENCY USING MODULATORY RNA MOLECULES
#256Regulatory B cells and their uses
#257Method of treating graft versus host disease
#258LIVER STROMAL CELLS FOR PREVENTION AND TREATMENT OF IMMUNE RESPONSES IN TRANSPLANTATION
#259BIOMARKERS AND USES THEREOF
#260HUCBC treatment of amyloid-associated disease
#261Modified natural killer T cells, pharmaceutical compositions and uses thereof
#262Hyperblebbing strains
#263METHODS OF TREATING INFLAMMATORY COLON DISEASES
#264METHODS OF PREVENTING PLATELET ALLOIMMUNIZATION AND ALLOIMMUNE PLATELET REFRACTORINESS AND INDUCTION OF TOLERANCE IN TRANSFUSED RECIPIENTS
#265Allograft tolerance induction
#266Therapy with cells from human placenta and hematopoietic cells
#267Immune competent models of human disease
#268Enhancer of survival of transplanted organ
#269Enhancer of survival of transplanted organ
#270Treatment of graft-versus-host disease
#271Human monocyte sub-population for treatment of eye diseases and disorders
#272Regulatory B cells (tBREGS) and their use
#273Methods and compositions for treating prostate cancer or inducing a humoral immune response against prostate cancer
#274Complexes of types of MHC class II that bind to collagen type II peptides and their use on diagnosis and treatment
#275Placental stem cell populations
#276Methods for treatment comprising an antibody that binds CD223 protein
#277Syndecan-2 compositions and methods of use
#278Adherent cells from placenta and use of same in disease treatment
#279Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs
#280Pharmaceutical composition for inhibiting immune response through inducing differentiation into regulator T cells and promoting proliferation of regulator T cells
#281Tolerogenic dendritic cells, method for their production and uses therof
#282Induced dendritic cells and uses thereof
#283METHODS AND MATERIALS FOR THE GENERATION OF REGULATORY T CELLS
#284Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
#285Immunomodulation by controlling expression levels of microRNAs in dendritic cells
#286Methods for treating chronic lymphocytic leukemia (CLL)
#287TREATMENT OF GRAFT VERSUS HOST DISEASE IN TRANSPLANT PATIENTS
#288Natural killer cells from placenta
#289Method for generation of regulatory T-cells using factors secreted by iNKT cells
#290Compositions for inducing or suppressing an immune response
#291USE OF CART19 TO DEPLETE NORMAL B CELLS TO INDUCE TOLERANCE
#292Allograft tolerance induction
#293Cell populations having immunoregulatory activity, method for isolation and uses
#294Hydroxylated KRN7000 analogue and use thereof
#295Method for inducing immune tolerance using non-proliferative polymer-modified allogeneic leukocytes
#296Modulation of the immune response
#297Human CD8 regulatory T cells inhibit GVHD and preserve general immunity in humanized mice
#298Acellular pro-tolerogenic compositions for treatment/prevention of graft rejection
#299CD127 expression inversely correlates with FoxP3 and suppressive function of CD4+ tregs
#300ENHANCEMENT OF PLACENTAL STEM CELL POTENCY USING MODULATORY RNA MOLECULES